Kern Medical recently hosted the 66th Annual Valley Fever multi-day conference, Coccidiodomycosis Study Group (CSG), with a series of educational events leading up to the big day called COCCI-CON.  This meeting included clinical and case presentations on ecology, epidemiology, basic science and veterinary.

These new COCCI-CON events will provide an even larger platform and opportunity for researchers, physicians, legislators and health partners to come together with the common goal to bring additional resources, identify funding needs and achieve consensus on Valley Fever research priorities.

“We all know people that Valley Fever has had devastating impacts on their lives.  We are grateful for the physicians and researchers at Kern Medical’s Valley Fever Institute and other institutions that work to find more effective treatments and hopefully someday a cure,” said Scott Thygerson, CEO at Kern Medical. For more information, please visit www.valleyfeverinstitute.com.